Mednet Logo
HomeRadiation OncologyQuestion

How would you approach treatment for a patient with locally advanced NSCLC and systemic scleroderma if chemoradiation is their only curative option?

5
1 Answers
Mednet Member
Mednet Member
Radiation Oncology · Mayo Clinic

My advice would be to provide some consent that there may be some increased risk of toxicity, especially esophageal, and then treat them as you would if they didn't have scleroderma. I think the literature suggesting scleroderma is contraindicated in radiotherapy is pretty soft. There's been some in...

Register or Sign In to see full answer